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Figure 2: Representation of the structure of 
the work divided in the relevant sectionsFigure 1: Alipogene tiparvovec, 
first approved drug for gene 
therapy for LPL deficiency
Figure 3: Comparison of the main characteristics of the cu-
rrently most used viral/non viral vectors
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Non viral methods
Figure 4: Germ-line modi-
fications may lead to con-
trol of the genome of futu-
re generations
Figure 5: Image 
of the front page 
of the work
Method Main advantages Main limitations
Microinjection Simple, efective, reproducible, non toxic,  
able to transfer large size DNA
Non suitable for transfecion of large 
number of cells
Needle injection Simple, safe Low efficiency
Gene gun Safe, efective Tissue damage
Electroporation Highly efective, reproducible, potential 
for localized gene delivery, able to trans-
fer large size DNA
Limited working range restricts gene 
delivery  to large area of tissue. Sur-
gical procedure  is required to trans-
fer  genes into internal organs. The 
stability  of genomic DNA might be 
influenced by high voltage.
Sonoporation Safe, non invasive, able to transfer genes 
into internal organs without surgical pro-
cedure, potential to disrupt blood-brain 
barrier
Low efficiency
Hydrodynamic 
gene transfer
Simple, reproducible, highly efective, (es-
pecially for liver gene delivery)
Large injection volume is required 
which restricts its clinical application
Mechanical mas-
sage
Simple, safe Low efficiency. Only has been repor-
ted for liver gene delivery
Cationic lipids Easy to be prepared, low cost, highly efec-
tive in vitro
Toxicity, low eficiency in vivo
Cationic polymers Easy to be prepared and chemically mo-
dified, low cost, effective
Toxicity. Some polymers are non-
biodegradable
